- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01298609
Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia
A Randomized Controlled Pilot Study to Examine the Efficacy of Greater Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia
The study is designed as a prospective, randomized, double-blind, single center study with a 6 month duration post permanent system implantation. Forty patients will be implanted.
During trial stimulation, patients will be randomized into one of two study arms for two weeks. Crossover will occur at the 2 week study visit to the opposite group. After completion of these two arms, every patient will subsequently complete participation in the third study arm.
After completion of the third arm, patients will be evaluated to determine if they are a positive responder responder. If so, the patient will have the option of obtaining the permanent implant.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Antwerpen, Belgio
- Universitair Ziekenhuis Antwerpen
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Patients able to provide informed consent to participate in the study;
- Patient has had chronic widespread pain for at least 3 months in all 4 body quadrants;
- Patient has at least 11 out of 18 tender points based on the tender points examination;
- Patient has attempted "best" medical therapy and has tried and failed at least three documented medically supervised treatments (including, but not limited to drugs, physical therapy, acupuncture, etc.);
- Patient medication has remained stable for at least 4 weeks prior to baseline data collection;
- Psychological screening has been completed and the patient has been cleared by a psychologist as a suitable study candidate;
- Patient agrees not to add or increase medication throughout the randomization trial period of the study;
- Patient is willing to cooperate with the study requirements including compliance with the treatment regimen and completion of all office visits.
Exclusion Criteria:
- Patient has current evidence of any psychiatric disorder, as documented by the DSM-IV-TR criteria with psychotic characteristics, (e.g. bipolar disorder, major depressive disorder);
- Patient has been diagnosed with any disease mimicking the symptoms of the Fibromyalgia Syndrome (e.g. Epstein Barr, autoimmune diseases, etc.) that is not currently being treated or has not been stable for at least 6 months;
- Patient is currently in active menopause;
- Patient has been diagnosed with sleep apnea and is not currently involved in a treatment regime;
- Patient has a history of substance abuse or substance dependency in the past 6 months prior to baseline data collection;
- Patient currently participating in another clinical study;
- Patient with demand-type cardiac pacemakers, an infusion pump or any implantable neurostimulator device;
- Patient is likely to require an MRI evaluation in the future;
- Patient is not willing to maintain current medication regimen;
- Female candidates of child bearing potential who are pregnant (confirmed by positive urine/blood pregnancy test), not using adequate contraception as determined by the investigator, or nursing (lactating) a child.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione incrociata
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Suprathreshold Stimulation
Patients will be stimulated at supra-sensory threshold levels for two weeks using occipital stimulation
|
Occipital Nerve Stimulation will be used in each study arm using the Eon Mini neuromodulation system
|
|
Comparatore fittizio: minimal stimulation
Patients will be stimulated at minimal stimulation for two weeks using occipital stimulation
|
Occipital Nerve Stimulation will be used in each study arm using the Eon Mini neuromodulation system
|
|
Comparatore attivo: Subthreshold Stimulation
Patients will be stimulated at sub-sensory threshold stimulation for two weeks using occipital stimulation
|
Occipital Nerve Stimulation will be used in each study arm using the Eon Mini neuromodulation system
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Fibromyalgia Impact Questionnaire (FIQ)
Lasso di tempo: End of 6 week stimulation trial
|
The Fibromyalgia Impact Questionnaire (FIQ) is a self administered scale that was developed to measure fibromyalgia patient status, progress and outcomes. It measures the components of health that are most affected by fibromyalgia. The maximum score is 100 and a higher score indicates a greater impact of the syndrome on the person. The change in the Fibromyalgia Impact Questionnaire (FIQ) will be analyzed and reported. |
End of 6 week stimulation trial
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- CRD_545
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Occipital Stimulation
-
University of British ColumbiaCompletatoStimolazione cerebrale profonda | Disfonia spasmodica | Distonia laringeaCanada
-
Insel Gruppe AG, University Hospital BernReclutamentoMetastasi al cervelloSvizzera
-
University of Sao PauloSconosciutoDisordine depressivo | Disordine bipolare | Episodio depressivoBrasile
-
University Hospital TuebingenCompletatoGrave depressioneGermania
-
Jung-Sun LeeSeoul St. Mary's Hospital, The Catholic University; Seoul National University... e altri collaboratoriNon ancora reclutamentoDisturbo depressivo maggiore (MDD) | Depressione - Disturbo depressivo maggioreCorea del Sud
-
University of FloridaReclutamento
-
University of Sao PauloAttivo, non reclutante
-
Biotronik, Inc.Biotronik Australia Pty Ltd.; BIOTRONIK NeuroAttivo, non reclutanteDolore lombare cronico | Dolore cronico alle gambeAustralia
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Ministry of Health, ItalyCompletatoSindrome di Tourette | Sindrome di Tourette | Disturbo di Tourette | Sindrome di Gilles de la TouretteItalia
-
The University of Texas Health Science Center,...Completato